Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia ...

In financial institutions across the United States, there’s a reflex that’s become almost ritual. When a regulator walks in, or a board member asks whether the AML program is working, the answer is ...

The Treasury Department is postponing its investment advisor anti-money laundering rule by two years and plans to “revisit the scope” of the regulation. The Department’s Financial Crimes Enforcement ...